James L. Abbruzzese
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research 216
- Colorectal Cancer Treatments and Studies 72
- Cancer Treatment and Pharmacology 30
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics 66
- Cancer, Hypoxia, and Metabolism 44
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis 32
- Pulmonary and Respiratory Medicine top 0.05%
- Gastric Cancer Management and Outcomes 33
- Molecular Biology top 0.1%
-
- Neuroendocrine Tumor Research Advances 51
- Co-authors
- Robert A. WolffDouglas B. EvansDonghui LiKeping XieRenato LenziHuamin WangGauri R. VaradhacharyKenneth R. Hess
- Cited by
- OncologyCancer ResearchHepatology
- Journals
- The Lancet (1 paper)Journal of Biological Chemistry (3 papers)Journal of Clinical Oncology (86 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
James L. Abbruzzese
511 papers receiving 42.4k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Oncology 25.9k
- Cancer Research 10.5k
- Hepatology 2.6k
- Pulmonary and Respiratory Medicine 8.6k
- Molecular Biology 16.1k
Countries citing papers authored by James L. Abbruzzese
This map shows the geographic impact of James L. Abbruzzese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Abbruzzese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Abbruzzese more than expected).
Fields of papers citing papers by James L. Abbruzzese
This network shows the impact of papers produced by James L. Abbruzzese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Abbruzzese. The network helps show where James L. Abbruzzese may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James L. Abbruzzese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 44 | |
| 2 | 2016 | 36 | |
| 3 | 2012 | 245 | |
| 4 | 2011 | 83 | |
| 5 | 2011 | 80 | |
| 6 | 2011 | 119 | |
| 7 | 2009 | 10 | |
| 8 | 2009 | 21 | |
| 9 | 2009 | 50 | |
| 10 | Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancerbreakdown → | 2009 | 729 |
| 11 | 2009 | 32 | |
| 12 | 2009 | 127 | |
| 13 | 2008 | 262 | |
| 14 | Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinomabreakdown → | 2006 | 794 |
| 15 | 2006 | 64 | |
| 16 | 2005 | 260 | |
| 17 | 2004 | 282 | |
| 18 | 2004 | 3 | |
| 19 | 1996 | 8 | |
| 20 | 1992 | 41 |
About James L. Abbruzzese
James L. Abbruzzese is a scholar working on Oncology, Cancer Research and Hepatology, having authored 513 papers that have together received 43.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (216 papers), Colorectal Cancer Treatments and Studies (72 papers), Cancer Genomics and Diagnostics (66 papers), Neuroendocrine Tumor Research Advances (51 papers), Cancer, Hypoxia, and Metabolism (44 papers), Gastric Cancer Management and Outcomes (33 papers), Hepatocellular Carcinoma Treatment and Prognosis (32 papers) and Cancer Treatment and Pharmacology (30 papers). The work is most often cited by research in Oncology (25.9k citations), Cancer Research (10.5k citations) and Hepatology (2.6k citations). James L. Abbruzzese has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Robert A. Wolff, Douglas B. Evans, Donghui Li, Keping Xie, Renato Lenzi, Huamin Wang, Gauri R. Varadhachary, Kenneth R. Hess, Peter W. T. Pisters and Paul J. Chiao. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.